Loading chat...
HI HCR191
Concurrent Resolution
Status
Introduced
3/12/2021
Primary Sponsor
John Mizuno
Click for details
AI Summary
- Urges the Smithsonian Institution to immediately rename the Arthur M. Sackler Gallery due to the Sackler family's role in the opioid crisis
- Identifies OxyContin, developed by Purdue Pharma (owned by the Sackler family), as central to the opioid epidemic that kills more people annually than motor vehicle accidents or gun violence
- Details the Sackler family's deceptive marketing campaign that misrepresented opioid risks to physicians and falsely promoted OxyContin's safety and non-addictive properties
- Cites psychiatrist Allen Frances's statement that Arthur Sackler's practices exemplified questionable pharmaceutical industry conduct
- Directs certified copies be sent to the Smithsonian Secretary, Inspector General, Chief Operating Officer, Assistant Secretary for Communications and External Affairs, and General Counsel
Legislative Description
Urging The Smithsonian Institution To Immediately Rename The Arthur M. Sackler Gallery.
Smithsonian Institution
Last Action
Report adopted. referred to the committee(s) on JHA as amended in HD 1 with Representative(s) D. Kobayashi, Okimoto voting aye with reservations; none voting no (0) and Representative(s) McDermott excused (1).
3/23/2021
Committee Referrals
Judiciary & Hawaiian Affairs3/23/2021
Culture, Arts, & International Affairs3/15/2021
Full Bill Text
No bill text available